Letter to the editor

Journal of Clinical Lipidology

Volumn 4, Issue 4, 2010, Pages 314-315

  Van Woerkom, Ryan C ^a   Adler, Douglas G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; EZETIMIBE PLUS SIMVASTATIN; PARACETAMOL; ROSUVASTATIN; AZETIDINE DERIVATIVE; EZETIMIBE; HYPOCHOLESTEROLEMIC AGENT; SIMVASTATIN;

ACUTE PANCREATITIS; ADULT; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIGASTRIC PAIN; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALAISE; MALE; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; TOXIC HEPATITIS; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HEPATITIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS;

ACUTE DISEASE; ANTICHOLESTEREMIC AGENTS; AZETIDINES; DRUG THERAPY, COMBINATION; HEPATITIS; HUMANS; HYPERCHOLESTEROLEMIA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NAUSEA; PANCREATITIS; SIMVASTATIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84865706964     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.03.075     Document Type: Letter

References (13)

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA. 2001;285:2486-2497.
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735-2752.
3. Pasternak RC, Smith SC Jr., Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation. 2002;106:1024-1028.
4. Singh S, Loke YK. Statins and pancreatitis: A systematic review of observational studies and spontaneous case reports. Drug Saf. 2006;29: 1123-1132.
5. Antonopoulos S, Mikros S, Kokkoris S, et al. A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment. J Pancreas. 2005;6:264-268.
6. Johnson JL, Loomis IB. A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis. Pharmacotherapy. 2006; 26:414-422.
7. van Heyningen C. Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe. Ann Clin Biochem. 2005;42:402-404.
8. Stolk MF, Becx MC, Kuypers KC, Seldenrijk CA. Severe hepatic side effects of ezetimibe. Clin Gastroenterol Hepatol. 2006;4:908-911.
9. Liu Q, Tobias H, Petrovic LM. Drug-induced liver injury associated with ezetimibe therapy. Dig Dis Sci. 2007;52:602-605.
10. Sabate M, Ibanez L, Perez E, et al. Risk of acute liver injury associated with the use of drugs: A multicentre population survey. Aliment Pharmacol Ther. 2007;25:1401-1409.
11. Castellote J, Ariza J, Rota R, Girbau A, Xiol X. Serious drug-induced liver disease secondary to ezetimibe. World J Gastroenterol. 2008;14: 5098-5099.
12. Robinson JG, Ballantyne CM, Grundy SM, et al. Lipid-altering efficacy and safety of ezetimibe/ simvastatin versus atorvastatin in patients with hypercholesterolemia and themetabolic syndrome (from the VYMET Study). Am J Cardiol. 2009;103:1694-1702.
13. Ahmad I, Ruby E, Usman H, Hotiana M, Hussain M, Rahman F. Ezetimibe-induced acute pancreatitis. South Med J. 2007;100: 409-410.